MedTrace Logo

Exclusive Intraoperative Radiation Therapy for Breast Cancer

NCT01276938 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-05-24

No results posted yet for this study

Summary

Aim of the study is to evaluate toxicity in breast cancer patients treated with two different doses of Intra Operative Radiotherapy

Conditions

  • Breast Neoplasms
  • Toxicity

Interventions

RADIATION

21 Gy radiation

21 Gy radiation using electrons produced with mobile linear accelerator (energies ranging from 4 to 10 MeV)

RADIATION

18 Gy radiation

18 Gy radiation using electrons produced with mobile linear accelerator (energies ranging from 4 to 10 MeV)

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

    lead OTHER

Principal Investigators

  • Marina Guenzi, MD · IRCCS AOU SanMartino IST

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01276938 on ClinicalTrials.gov